If I were the head of a funding agency, I will be most likely to award funding for researchers that are focusing on the control of inflammatory bowel disease using probiotic, prebiotics, and synbiotics. The reviews we have read in this term “Systematic revies of randomized controlled trials of probiotics, prebiotics, and synbiotic inflammatory bowel disease”. briefly discussed many previous studies and the results of researchers using probiotics, prebiotics, and synbiotics. However, different studies have shown to have different results; some of them are counteractive to each other. There are some suggestions that probiotic may be comparably beneficial to the standard therapy of IBD which is aminosalicylates. However, different scenarios of IBD requires different treatments and some of the cases, either probiotic, prebiotics, and synbiotics would help. A more narrative research should be performed to figure these out. The results of the experiment would be helpful and beneficial to the future health care.
